CAS 2072873-06-2

Sintilimab

CAS: 2072873-06-2

Sintilimab (IBI308), an IgG4 monoclonal antibody, blocks PD-1, enhancing T-cell anti-tumor response; treats Hodgkin's, lung, and esophageal cancers.

Reinheit: > 95% - >95.0% (SDS-PAGE); 95.0% (SEC-HPLC)

Farbe und Form: Liquid

Molekulargewicht: 143.78 kDa

Ref: TM-T35394

Sintilimab

CAS: 2072873-06-2

Anti-Human PD-1 Monoclonal Antibody

Ref: 3D-CLA1540